About: Cell-bound complement activation products

An Entity of Type: Thing, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Cell-Bound Complement Activation Products (CB-CAPs) or complement split products, refers to complement activation fragments, C4d, that are bound covalently to somatic cells, as a result of activation of the classical complement pathway. They appear potentially useful for the diagnosis of systemic lupus erythematosus as of 2015.

Property Value
dbo:abstract
  • Cell-Bound Complement Activation Products (CB-CAPs) or complement split products, refers to complement activation fragments, C4d, that are bound covalently to somatic cells, as a result of activation of the classical complement pathway. They appear potentially useful for the diagnosis of systemic lupus erythematosus as of 2015. (en)
dbo:wikiPageID
  • 61066228 (xsd:integer)
dbo:wikiPageLength
  • 2466 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 979174252 (xsd:integer)
dbo:wikiPageWikiLink
dcterms:subject
rdfs:comment
  • Cell-Bound Complement Activation Products (CB-CAPs) or complement split products, refers to complement activation fragments, C4d, that are bound covalently to somatic cells, as a result of activation of the classical complement pathway. They appear potentially useful for the diagnosis of systemic lupus erythematosus as of 2015. (en)
rdfs:label
  • Cell-bound complement activation products (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License